Back
37
Day Range
$19.27
$19.91
52-Week Range
$9.13
$22.98
Volume
421,143
50D / 200D Avg
$19.94
/
$17.19
Prev Close
$19.38
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 23.5 | 0.3 |
| P/B | 2.7 | 3.0 |
| ROE % | 11.7 | 3.7 |
| Net Margin % | 3.2 | 3.8 |
| Rev Growth 5Y % | 2.9 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$23.33
+18.5%
Low: $22.00
High: $25.00
Forward P/E
20.27
Forward EPS
$0.96
EPS Growth (est.)
+0.0%
Est. Revenue
1.93B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$1.33
$1.32 – $1.33
|
2.13B | 1 |
| FY2027 |
$1.10
$1.09 – $1.10
|
2.04B | 3 |
| FY2026 |
$0.96
$0.96 – $0.97
|
1.93B | 3 |
No quarterly estimates available
Dividend History
4 yr streakYield
0.00%
Payout Ratio
0.00%
Growth (3Y)
12.69%
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Nov 17, 2022 | Dec 22, 2022 | $0.22 | 6.27% |
| Aug 18, 2022 | Sep 23, 2022 | $0.21 | 5.70% |
| May 19, 2022 | Jun 24, 2022 | $0.21 | 4.99% |
| Feb 24, 2022 | Mar 25, 2022 | $0.21 | 5.35% |
| Nov 18, 2021 | Dec 23, 2021 | $0.21 | 4.41% |
| Aug 19, 2021 | Sep 24, 2021 | $0.21 | 3.30% |
| May 20, 2021 | Jun 25, 2021 | $0.21 | 2.72% |
| Feb 25, 2021 | Mar 26, 2021 | $0.21 | 2.86% |
| Nov 19, 2020 | Dec 24, 2020 | $0.21 | 3.54% |
| Aug 20, 2020 | Sep 25, 2020 | $0.20 | 3.71% |
| May 21, 2020 | Jun 26, 2020 | $0.20 | 3.65% |
| Feb 27, 2020 | Mar 27, 2020 | $0.20 | 2.66% |
| Nov 21, 2019 | Dec 27, 2019 | $0.20 | 3.27% |
| Aug 22, 2019 | Sep 27, 2019 | $0.20 | 3.55% |
| May 23, 2019 | Jun 28, 2019 | $0.20 | 2.41% |
| Feb 14, 2019 | Mar 22, 2019 | $0.20 | 1.96% |
| Nov 21, 2018 | Dec 28, 2018 | $0.20 | 1.72% |
| Aug 23, 2018 | Sep 28, 2018 | $0.19 | 1.87% |
| May 24, 2018 | Jun 29, 2018 | $0.19 | 2.08% |
| Feb 15, 2018 | Mar 23, 2018 | $0.19 | 1.54% |
Key Takeaways
Revenue grew 2.85% annually over 5 years — modest growth
Earnings grew 49.63% over the past year
ROE of 11.69% — decent returns on equity
Debt/Equity of 0.05 — conservative balance sheet
Generating 139.15M in free cash flow
PEG of 0.45 suggests growth is underpriced
Growth
Revenue Growth (5Y)
2.85%
Revenue (1Y)7.08%
Earnings (1Y)49.63%
FCF Growth (3Y)91.13%
Quality
Return on Equity
11.69%
ROIC6.81%
Net Margin3.21%
Op. Margin2.64%
Safety
Debt / Equity
0.05
Current Ratio3.38
Interest Coverage30.72
Valuation
P/E Ratio
23.49
Forward P/E20.27
P/B Ratio2.72
EV/EBITDA25.77
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.08% | Revenue Growth (3Y) | 4.84% |
| Earnings Growth (1Y) | 49.63% | Earnings Growth (3Y) | 24.04% |
| Revenue Growth (5Y) | 2.85% | Earnings Growth (5Y) | 5.02% |
| Profitability | |||
| Revenue (TTM) | 1.84B | Net Income (TTM) | 59.06M |
| ROE | 11.69% | ROA | 7.31% |
| Gross Margin | 13.03% | Operating Margin | 2.64% |
| Net Margin | 3.21% | Free Cash Flow (TTM) | 139.15M |
| ROIC | 6.81% | FCF Growth (3Y) | 91.13% |
| Safety | |||
| Debt / Equity | 0.05 | Current Ratio | 3.38 |
| Interest Coverage | 30.72 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | 12.69% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 4 yrs | ||
| Valuation | |||
| P/E Ratio | 23.49 | Forward P/E | 20.27 |
| P/B Ratio | 2.72 | P/S Ratio | 0.76 |
| PEG Ratio | 0.45 | Forward PEG | N/A |
| EV/EBITDA | 25.77 | Fwd EV/EBITDA | 15.35 |
| Forward P/S | 0.72 | Fwd Earnings Yield | 4.93% |
| FCF Yield | 10.03% | ||
| Market Cap | 1.39B | Enterprise Value | 1.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.84B | 1.72B | 1.67B | 1.69B | 1.64B |
| Net Income | 59.06M | 39.47M | 38.39M | 34.24M | 48.54M |
| EPS (Diluted) | 0.81 | 0.53 | 0.52 | 0.46 | 0.65 |
| Gross Profit | 239.41M | 228.09M | 214.75M | 193.31M | 230.57M |
| Operating Income | 48.54M | 53.27M | 54.66M | 43.79M | 64.13M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 807.78M | 815.47M | 803.18M | 718.33M | 786.80M |
| Total Liabilities | 297.57M | 315.55M | 346.57M | 292.16M | 334.12M |
| Shareholders' Equity | 510.21M | 499.93M | 456.62M | 426.17M | 452.68M |
| Total Debt | 24.68M | 16.43M | 43.64M | 33.10M | 17.80M |
| Cash & Equivalents | 161.12M | 85.24M | 54.33M | 26.28M | 70.79M |
| Current Assets | 576.42M | 556.65M | 571.70M | 508.63M | 546.38M |
| Current Liabilities | 170.38M | 192.55M | 216.93M | 178.62M | 191.13M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#692 of 1052
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026